VivoSim Labs, INC.
VIVSNasdaqCIK 1497253HealthcareFiscal year ends Mar 31
Reports and events: 289 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-1620:05 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-424061 |
| 2026-10-0620:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-415542 |
| 2026-08-2120:05 ET | 8-K | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001193125-26-361085 |
| 2026-08-2120:02 ET | DEF 14A | Proxy statementPeriod 2026-09-30 | 0001193125-26-361066 |
| 2026-08-1220:06 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-346820 |
| 2026-08-0612:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-336844 |
| 2026-07-3120:16 ET | S-1 | Registration statement | 0001193125-26-328613 |
| 2026-07-3020:12 ET | 8-K | 5.08 Item not in the standard list; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-326139 |
| 2026-07-2420:07 ET | 8-K | 3.01 Delisting notice; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-081377 |
| 2026-07-1712:45 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-306849 |
| 2026-07-1420:50 ET | 10-K | Annual reportPeriod 2026-03-31 | 0001193125-26-303316 |
| 2026-04-0320:05 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-142106 |
| 2026-03-3114:17 ET | S-1/A | Registration statement, amended | 0001213900-26-037009 |
| 2026-03-2721:26 ET | S-1 | Registration statement | 0001213900-26-035742 |
| 2026-02-1121:05 ET | 10-Q | Quarterly reportPeriod 2025-12-31 | 0001193125-26-046520 |
| 2025-12-1821:05 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-25-324794 |
| 2025-11-0621:08 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-269483 |
| 2025-11-0321:06 ET | DEF 14A | Proxy statementPeriod 2025-12-16 | 0001193125-25-262543 |
| 2025-08-1412:06 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-108447 |
| 2025-08-1220:05 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-107284 |
| 2025-07-2920:05 ET | 10-K/A | Annual report, amendedPeriod 2025-03-31 | 0000950170-25-099620 |
| 2025-06-0520:05 ET | 10-K | Annual reportPeriod 2025-03-31 | 0000950170-25-082312 |
| 2025-05-0612:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-063979 |
| 2025-04-2412:30 ET | 8-K | 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-057685 |
| 2025-04-2312:06 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-056974 |
| 2025-04-0212:06 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-048888 |
| 2025-03-2712:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-045740 |
| 2025-03-2612:05 ET | 8-K | 2.01 Completion of an acquisition or disposition; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-044801 |
| 2025-03-2112:05 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0000950170-25-042903 |
| 2025-03-1912:06 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-041749 |
| 2025-03-0613:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-034181 |
| 2025-02-2513:06 ET | 8-K | 1.01 Entry into a material agreement; 3.01 Delisting notice; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-026097 |
| 2025-02-1914:00 ET | 10-Q | Quarterly reportPeriod 2024-12-31 | 0000950170-25-022778 |
| 2025-01-1722:30 ET | 8-K | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0000950170-25-006819 |
| 2024-12-3113:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-24-141323 |
| 2024-11-2213:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-24-129965 |
| 2024-11-0821:04 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-124044 |
| 2024-10-2521:00 ET | S-1 | Registration statement | 0000950170-24-117458 |
| 2024-10-0720:05 ET | DEF 14A | Proxy statementPeriod 2024-10-04 | 0000950170-24-113206 |
| 2024-08-0920:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-24-094736 |
| 2024-08-0520:05 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-090726 |
| 2024-07-2620:05 ET | 10-K/A | Annual report, amendedPeriod 2024-03-31 | 0000950170-24-086880 |
| 2024-07-2420:05 ET | 8-K | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0000950170-24-086026 |
| 2024-05-3120:05 ET | 10-K | Annual reportPeriod 2024-03-31 | 0000950170-24-067301 |
| 2024-05-1321:00 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-058805 |
| 2024-05-0112:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-050906 |
| 2024-04-3021:30 ET | S-1/A | Registration statement, amended | 0000950170-24-050663 |
| 2024-04-2320:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-046879 |
| 2024-04-1221:16 ET | S-1 | Registration statement | 0000950170-24-044137 |
| 2024-02-0821:05 ET | 10-Q | Quarterly reportPeriod 2023-12-31 | 0000950170-24-012754 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.